Suchergebnisse - "Torres Macho, Juan"

PubPharm (94)

21

Neuropathic post-COVID pain symptomatology is not associated with serological biomarkers at hospital admission and hospitalization treatment in COVID-19 survivors

enthalten in: Frontiers in medicine | 2023

von Fernández-de-Las-Peñas, C. | Guijarro, C. | Velasco-Arribas, M. | +5

22

Could We Consider Ultrasound‐Guided Minimally Invasive Autopsy as a Part of POCUS?

enthalten in: Journal of Ultrasound in Medicine | 2023

von Casado‐Suela, M. | Cuevas‐Tascón, G. | Cabezas Quintario, M. | +7

23

Lung ultrasound must be the first-line image technique in COVID-19 patients

enthalten in: European journal of internal medicine | 2023

von Torres-Macho, J. | Casado-Suela, M. | Duffort-Falcó, M.

CommentOn: Eur J Intern Med. 2023 Apr;110:29-34. - PMID 36564240

24

Development of Neuropathic Post-COVID Pain Symptoms Is Not Associated with Serological Biomarkers at Hospital Admission in COVID-19 Survivors : A Secondary Analysis

enthalten in: Pain medicine (Malden, Mass.) | 2022

von Fernández-de-Las-Peñas, C. | Herrero-Montes, M. | Ferrer-Pargada, D. | +5

25

Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern : A Systematic Review of the Literature

enthalten in: Viruses | 2022

von Fernández-de-Las-Peñas, C. | Notarte, K. | Peligro, P. | +6

26

Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivors

enthalten in: Pain | 2022

von Fernández-de-Las-Peñas, C. | Ryan-Murua, P. | de-la-Llave-Rincón, A. | +3

27

Headache as a COVID-19 onset symptom and post-COVID-19 symptom in hospitalized COVID-19 survivors infected with the Wuhan, Alpha, or Delta SARS-CoV-2 variants

enthalten in: Headache | 2022

von Fernández-de-Las-Peñas, C. | Cuadrado, M. | Gómez-Mayordomo, V. | +4

28

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19 : The PROTHROMCOVID Randomized Controlled Trial

enthalten in: Journal of clinical medicine | 2022

von Muñoz-Rivas, N. | Aibar, J. | Gabara-Xancó, C. | +18

29

Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19) : study protocol for a randomized controlled trial

enthalten in: Trials | 2022

von Franco-Moreno, A. | Acedo-Gutiérrez, M. | Martín, N. | +22

30

Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial

enthalten in: Trials | 2022

von Franco-Moreno, A. | Acedo-Gutiérrez, M. | Martín, N. | +22